Navigation Links
Antibiotic Combo Fights Resistant TB
Date:2/26/2009

2 FDA-approved drugs inhibit both normal and virulent strains, study finds

THURSDAY, Feb. 26 (HealthDay News) -- Combination treatment with two FDA-approved drugs shows promise in treating extensively drug-resistant tuberculosis (XDR-TB), a U.S. study shows.

In laboratory tests, researchers at the Albert Einstein College of Medicine and the National Institute of Allergy and Infectious Diseases found that a combination of the drugs clavulanate and meropenem inhibited the growth of 13 XDR-TB strains. The combination treatment was also effective against normal TB. Both drugs are approved in the United States for treating other bacterial infections in adults and children.

The study was published in the Feb. 27 issue of Science.

Current therapy for normal TB requires four antibiotics that must be taken for at least six months. XDR-TB is resistant to at least four of the drugs used to treat TB. The cure rate for patients with XDR-TB is 12 percent to 60 percent.

"If proven in human subjects, the ability to simplify treatment to just two drugs that work against drug-susceptible [TB], multi-drug-resistant [TB] and XDR-TB could help patients better adhere to therapy," study senior author John S. Blanchard, a professor of biochemistry at Einstein, said in a college news release.

"This discovery could be one of the most promising developments in TB research since the discovery of isoniazid -- it is very exciting," William Jacobs, a professor of microbiology and immunology at Einstein and associate director of the Einstein-Montefiore Center for AIDS Research, said in the news release. Isoniazid, the first effective anti-tuberculosis medication, was discovered in the 1950s.

Plans are under way for clinical studies in Korea and in South Africa to determine whether the combination treatment is effective in patients with XDR-TB.

This highly dangerous form of TB is rare in the United States, with only 83 documented cases in the country between 1993 and 2007. However, XDR-TB is emerging as a serious problem in some developing nations.

More information

The U.S. Centers for Disease Control and Prevention has more about XDR-TB.



-- Robert Preidt



SOURCE: Albert Einstein College of Medicine, news release, Feb. 26, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New antibiotic drug combo to speed up treatment of tuberculosis
2. Newer Antibiotic Speeds TB Healing
3. Antibiotics Not Always Best Bet for Battling Childhood Ear Infections
4. Antibiotic Shows Promise as Stroke Treatment
5. Ear infection superbug discovered to be resistant to all pediatric antibiotics
6. Antibiotics May Not Help Mens Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives
7. Study Shows Antibiotic Harms ALS Patients
8. Dragon Sells EPO Business; Focus on Antibiotic Core Business
9. Drug Combo With Antibiotic May Slow MS Progression
10. Antibiotic treatment targets difficult asthma
11. New Report Underscores Need for Congressional Action to Limit Antibiotic Use in Animal Agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antibiotic Combo Fights Resistant TB
(Date:12/9/2016)... ... 2016 , ... The Justin Veatch Fund announced Thursday that ... film Whispering Spirits and its discussion guide for use by all of ... in the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated ... new solution for Emergency Departments (ED) has been added to their portfolio. Housed ... examination rooms, and with a simplified pallet of information available to the patient, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... global biosurgery market is expected to grow at a ... to 2021. The market is poised to reach USD ... 2016. The market is primarily driven by rising number ... spinal problems, increasing clearance of biosurgery products by regulatory ... In this report, the biosurgery market is ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... grow in 2017-2023. Various reasons for growth of the ... higher incidences of chronic diseases, high recovery cost of ... services. Medical lifting sling refers to an assistive ... mobility. These slings connect to the lift and hold ...
Breaking Medicine Technology: